Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Emulfin ointment
130201000BBMADM
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Eucerin Anti-Redness Calming Night cream
130201000BBLFA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Eucerin Anti-Redness Neutralising Day fluid
130201000BBLGA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Eucerin Dry Skin Relief soothing spray
130201000BBJYA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Eumobase cream
130201000BBKBA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Eumocream 25% cream
130201000BBKQCL
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Evening primrose oil 0.87% cream
130201000AACYCY
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Alcoderm cream
130201000AAARAR
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic AquaBar
130201000AACHCH
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Aveeno Daily moisturising hand cream
130201000AADQDQ
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Aveeno lotion
130201000AACBCB
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Diprobase cream
130201000AAA4A4
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Unguentum M cream
130201000AAA5A5
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Vaseline Dermacare lotion
130201000AAATAT
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Glycerol 10% in Cetomacrogol cream (Formula A)
130201000AACZCZ
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Glycerol 25% cream
130201000AACLCL
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Hewletts cream
130201000BBBSAX
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Kamillosan baby cream
130201000BBBTA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Kamillosan Chamomile 10.5% ointment
130201000BBBYAQ
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Keri Therapeutic lotion
130201000BBCBAS
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Lactic acid 5% / Sodium pidolate 2.5% lotion
130201000AACECE
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
LactiCare lotion
130201000BBJRCE
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Linola Gamma 20% cream
130201000BBKACG
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Liquid paraffin 16% lotion
130201000AAASAS
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Lotil foot cream
130201000BBLZA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.